Hints and tips:
...Nonetheless, James Shin, a biopharma analyst at Deutsche Bank, said the sharp increase in biosimilar prescriptions in recent weeks would be “alarming” to AbbVie....
...He previously led Wells Fargo’s biopharma investment banking unit....
...changes at GSK came as the UK drugmaker confirmed last week that it would press ahead with plans to separate its consumer health division next year, leaving a slimmed-down business focused entirely on biopharma...
...Instead, Elliott’s focus may be on what GSK will look like as a biopharma....
...GSK confirmed last month it would go ahead with plans to spin off its consumer health division next year, creating a “New GSK” focused on innovative biopharma....
...Smart read A new study finds that biopharma companies’ ESG disclosures are short on targets and prone to boilerplate descriptions....
...SK Corp gained 6 per cent in Seoul on Wednesday, a day after the group announced that it aimed to raise Won959.3bn ($780m) by floating subsidiary SK Biopharmaceuticals on the country’s bourse next month....
...“Together with Celgene, we will create a premier innovative biopharma company with leading scientific capabilities that is well positioned to address the needs of patients through high-value innovative medicines...
...GE’s biopharma business has annual revenues of about $3bn, about two-thirds of the total sales of the life sciences operations....
Shares in biopharma unit down by as much as 20%
Doubts hang over acquisitions struck when the industry was in the grip of an M&A frenzy
...Roivant is investing in Arbutus Biopharma via convertible preferred shares — a hybrid of debt and equity that allows the company to change its investment into common stock at a later date....
Investors are drawn to the low-volume, high-margin model
...According to estimates from Silicon Valley Bank, more than 40 per cent of venture capital backed “biopharma” companies that came to the market in 2014 were yet to complete phase 1 trials or were pre-clinical...
...But revenues rose 3 per cent to SKr28.4bn in the fourth quarter, helped by the acquisition last year of CTI, the Chile-based home appliance company, and Olympic Group, the biggest appliance maker in the...
...As part of the deal, Electrolux will also begin a cash tender offer of 325 pesos a share for Somela, a CTI subsidiary....
...Various Artists CTI Records: The Cool Revolution (Sony) The four CDs of this 40th anniversary collection are cherry-picked from the vintage years of producer Creed Taylor’s ultra-sharp record label CTI...
...Other companies that are starting to prepare plans for an Aim flotation are Port Erin Biopharma Investments and Jellybook, which will invest in social media businesses....
...The deal leaves Pearson with about £500m yet to spend from its disposal in May of a 61 per cent stake in the Interactive Data Corp financial information business....
...After working in Mexico and Brazil, he became Europe head in 2000, taking on a global biopharma role in 2006. He also sits on the board of US tissue maker Kimberly-Clark. people@ft.com...
...Unsurprisingly, the list is packed with futuristic-sounding names like GigOptix, Cytrix, Keryx Biopharma, Affymetrix and Oncogenex that offer technological promise but scant profits....
...In the pharmaceutical sector, Array BioPharma tumbled 23.3 per cent to $2.90. The company said a drug it was developing for rheumatoid arthritis had failed in a trial....
...After inquiries from the FT, the two directors who met the shareholder rebels last month sent Mr Schuler a letter last Friday agreeing to appoint two new board members – a ”suitably experienced biopharma...
...In a showcase project, Microsoft and partner Post CTI set up an alert system using instant messaging and smartphones for Tayside Fire and Rescue to call out its volunteer firemen....
...Shares in PDL BioPharma plunged 20.3 per cent to $18.80 after the developer of technology for cancer medicines announced a restructuring and was downgraded by JPMorgan Chase....
International Edition